Augmedix Inc. (AUGX)
NASDAQ: AUGX
· Real-Time Price · USD
2.35
0.00 (0.00%)
At close: Oct 01, 2024, 9:57 PM
Augmedix Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -23.85M | -20.43M | -19.17M | -20.28M | -21.34M | -23.75M | -24.45M | -24.3M | -21.69M | -18.88M | -17.85M | -16.37M | -17.63M | -15.95M |
Depreciation & Amortization | 1.62M | 1.47M | 1.31M | 1.25M | 676K | 796K | 856K | 775K | 1.04M | 828.41K | 691K | 745K | 803K | 851.94K |
Stock-Based Compensation | 3.41M | 2.82M | 2.47M | 2.46M | 2.29M | 2.22M | 2.11M | 1.78M | 1.68M | 1.43M | 1.39M | 1.17M | 899K | 955.1K |
Other Working Capital | 1.9M | 733K | 3.18M | -1.08M | -206K | -227K | -2.12M | 625K | -1.45M | -1.85M | 378K | 235K | 982K | 164.8K |
Other Non-Cash Items | 9.4M | 7.62M | 2.23M | 3.81M | 2.59M | 3.46M | 5.96M | 2.79M | 2.38M | 1.46M | 1.24M | 737K | 488K | 5.98K |
Deferred Income Tax | -3.05M | -2.94M | -2.94M | -1.48M | 113K | n/a | n/a | -38K | -2.22M | -2.22M | -2.06M | -2.04M | 719K | 734.44K |
Change in Working Capital | 1.29M | -3.42M | 652K | -4.62M | -4.43M | -1.56M | -1.25M | 1.32M | -784K | -65.24K | -2M | -1.65M | 1.02M | -678.15K |
Operating Cash Flow | -15.39M | -17.46M | -15.44M | -18.85M | -20.09M | -18.84M | -16.77M | -17.67M | -19.59M | -17.45M | -18.59M | -17.41M | -13.7M | -14.08M |
Capital Expenditures | -2.56M | -3.5M | -3.1M | -2.5M | -2.27M | -1.13M | -1.41M | -1M | -908K | -906.65K | -611K | -643K | -650K | -547.83K |
Cash Acquisitions | 27K | 26K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 31K | 26K | n/a | -5K | -5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -2.53M | -3.48M | -3.11M | -2.51M | -2.27M | -1.13M | -1.41M | -1M | -908K | -906.65K | -611K | -643K | -650K | -547.83K |
Debt Repayment | n/a | n/a | 5M | 5M | 5M | 3.88M | -1.13M | -1.13M | -1.13M | n/a | 2.03M | 1.53M | 1.53M | 3.71M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -356K | 11.45M | 11.48M | 12.03M | 11.98M | -40K | -112K | 35.83M | 35.82M | 36.02M | 1.86B | 1.84B | 1.84B | 1.84B |
Financial Cash Flow | 26.61M | 38.34M | 43.37M | 17M | 16.98M | 3.83M | -1.24M | 34.7M | 34.7M | 36.02M | 37.83M | 25.74M | 25.62M | 27.74M |
Net Cash Flow | 3.53M | 17.36M | 24.92M | -4.71M | -5.52M | -16.34M | -19.6M | 15.88M | 14.09M | 17.65M | 18.61M | 7.69M | 11.27M | 13.11M |
Free Cash Flow | -17.95M | -20.96M | -18.55M | -21.36M | -22.36M | -19.96M | -18.18M | -18.67M | -20.5M | -18.36M | -19.2M | -18.05M | -14.35M | -14.63M |